These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 8062492)
1. The kinetic profiles of enalapril and enalaprilat and their possible developmental changes in pediatric patients with congestive heart failure. Nakamura H; Ishii M; Sugimura T; Chiba K; Kato H; Ishizaki T Clin Pharmacol Ther; 1994 Aug; 56(2):160-8. PubMed ID: 8062492 [TBL] [Abstract][Full Text] [Related]
2. Characterization of the pharmacokinetic and pharmacodynamic properties of the angiotensin-converting enzyme inhibitor, enalapril, in horses. Gardner SY; Atkins CE; Sams RA; Schwabenton AB; Papich MG J Vet Intern Med; 2004; 18(2):231-7. PubMed ID: 15058776 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and pharmacodynamics of enalapril and its active metabolite, enalaprilat, at four different doses in healthy horses. Gómez-Díez M; Muñoz A; Caballero JM; Riber C; Castejón F; Serrano-Rodríguez JM Res Vet Sci; 2014 Aug; 97(1):105-10. PubMed ID: 24972864 [TBL] [Abstract][Full Text] [Related]
5. Determination of enalapril and enalaprilat by enzyme linked immunosorbent assays: application to pharmacokinetic and pharmacodynamic analysis. Matalka K; Arafat T; Hamad M; Jehanli A Fundam Clin Pharmacol; 2002 Jun; 16(3):237-44. PubMed ID: 12165071 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and pharmacodynamics profiles of enalapril maleate in healthy volunteers following determination of enalapril and enalaprilat by two specific enzyme immunoassays. Arafat T; Awad R; Hamad M; Azzam R; Al-Nasan A; Jehanli A; Matalka K J Clin Pharm Ther; 2005 Aug; 30(4):319-28. PubMed ID: 15985045 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of enalapril in congestive heart failure. Dickstein K Drugs; 1986; 32 Suppl 5():40-4. PubMed ID: 3032562 [TBL] [Abstract][Full Text] [Related]
8. Systemic and coronary haemodynamics and pharmacodynamics of enalapril and enalaprilat in congestive heart failure. Chatterjee K; De Marco T Drugs; 1990; 39 Suppl 4():29-40; discussion 41-2. PubMed ID: 2162294 [TBL] [Abstract][Full Text] [Related]
9. Effect of organic anion-transporting polypeptide 1B1 (OATP1B1) polymorphism on the single- and multiple-dose pharmacokinetics of enalapril in healthy Chinese adult men. Tian L; Liu H; Xie S; Jiang J; Han L; Huang Y; Li Y Clin Ther; 2011 May; 33(5):655-63. PubMed ID: 21665049 [TBL] [Abstract][Full Text] [Related]
10. The pharmacokinetics of enalapril in hospitalized patients with congestive heart failure. Dickstein K; Till AE; Aarsland T; Tjelta K; Abrahamsen AM; Kristianson K; Gomez HJ; Gregg H; Hichens M Br J Clin Pharmacol; 1987 Apr; 23(4):403-10. PubMed ID: 3034316 [TBL] [Abstract][Full Text] [Related]
11. Enalapril pharmacokinetics and ACE inhibition, following single and chronic oral dosing. Edeki T; Johnston A; Li Kam Wa E; Turner P Int J Clin Pharmacol Ther; 1994 Mar; 32(3):142-6. PubMed ID: 8205376 [TBL] [Abstract][Full Text] [Related]
12. The pharmacokinetics of enalapril in children and infants with hypertension. Wells T; Rippley R; Hogg R; Sakarcan A; Blowey D; Walson P; Vogt B; Delucchi A; Lo MW; Hand E; Panebianco D; Shaw W; Shahinfar S J Clin Pharmacol; 2001 Oct; 41(10):1064-74. PubMed ID: 11583474 [TBL] [Abstract][Full Text] [Related]
13. Determination of enalapril and enalaprilat in small human serum quantities for pediatric trials by HPLC-tandem mass spectrometry. Ramusovic S; Thielking G; Läer S Biomed Chromatogr; 2012 Jun; 26(6):697-702. PubMed ID: 21953651 [TBL] [Abstract][Full Text] [Related]
14. Clinical pharmacokinetics of the angiotensin converting enzyme inhibitors. A review. Kubo SH; Cody RJ Clin Pharmacokinet; 1985; 10(5):377-91. PubMed ID: 2994938 [TBL] [Abstract][Full Text] [Related]
15. Within-patient comparison of effects of different dosages of enalapril on functional capacity and neurohormone levels in patients with chronic heart failure. Brunner-La Rocca HP; Weilenmann D; Kiowski W; Maly FE; Candinas R; Follath F Am Heart J; 1999 Oct; 138(4 Pt 1):654-62. PubMed ID: 10502210 [TBL] [Abstract][Full Text] [Related]
16. Bioequivalence study of two enalapril maleate tablet formulations in healthy male volunteers. Pharmacokinetic versus pharmacodynamic approach. Ribeiro W; Muscará MN; Martins AR; Moreno H; Mendes GB; de Nucci G Eur J Clin Pharmacol; 1996; 50(5):399-405. PubMed ID: 8839663 [TBL] [Abstract][Full Text] [Related]
17. Kinetics and dynamics of enalapril in patients with liver cirrhosis. Ohnishi A; Tsuboi Y; Ishizaki T; Kubota K; Ohno T; Yoshida H; Kanezaki A; Tanaka T Clin Pharmacol Ther; 1989 Jun; 45(6):657-65. PubMed ID: 2543535 [TBL] [Abstract][Full Text] [Related]
18. Comparison of the pharmacokinetics of fosinoprilat with enalaprilat and lisinopril in patients with congestive heart failure and chronic renal insufficiency. Greenbaum R; Zucchelli P; Caspi A; Nouriel H; Paz R; Sclarovsky S; O'Grady P; Yee KF; Liao WC; Mangold B Br J Clin Pharmacol; 2000 Jan; 49(1):23-31. PubMed ID: 10606834 [TBL] [Abstract][Full Text] [Related]